Randall S. Livingston's most recent trade in Pacific Biosciences of California Inc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 22,821 (0%) | 0% | 0 | Common Stock | |
| eHealth Inc | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 16,560 | 63,338 (0%) | 0% | 0 | Common Stock | |
| eHealth Inc | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 3,221 | 46,778 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,885 | 12,885 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Sale of securities on an exchange or to another person at price $ 48.07 per share. | 12 Feb 2021 | 67,500 | 0 (0%) | 0% | 48.1 | 3,244,455 | Common Stock |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 12 Feb 2021 | 25,000 | 67,500 (0%) | 0% | 2.5 | 63,500 | Common Stock |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.83 per share. | 12 Feb 2021 | 25,000 | 42,500 (0%) | 0% | 1.8 | 45,750 | Common Stock |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 17,500 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Randall S. Livingston | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.58 per share. | 12 Feb 2021 | 17,500 | 17,500 (0%) | 0% | 10.6 | 185,150 | Common Stock |